NASHVILLE, Tenn., Jan. 30, 2018 /PRNewswire/ — Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a U.S. specialty pharmaceutical company and Clinigen Group plc (AIM: CLIN, ‘Clinigen’), the global pharmaceutical and services company, announce a new publication in Leukemia & Lymphoma,…
